ERBB2 and breast cancer: Univariate and multivariate results showed that the low CONUT score group had better overall survival and recurrence-free survival than the high CONUT group.<h4>Conclusion</h4>CONUT score is an independent predictor of postoperative recurrence and metastasis in HER2-low breast cancer patients.